Biotech3 years ago
Minoryx Therapeutics Raises 51M to Complete Commercialization of its CNS drug
Minoryx Therapeutics, based in Mataró (Barcelona), will also finance the activities necessary to be able to proceed with the approval of leriglitazone in the United States...